According to a press release from PR Newswire on September 11th, e-cigarette brand VAPORESSO has announced that it has become the first registered e-cigarette brand approved by the Ministry of Industry and Advanced Technology (MoIAT) in the United Arab Emirates (UAE) for sales in the country.
Vaporesso has announced that after nearly a year of strategic planning and application, the company has successfully obtained product certification from the Ministry of Industry, Advanced Technology (MoIAT). This certification covers 11 different models, including Luxe XR, XROS 3 Mini, XROS 2, XROS 3, XROS Mini, XROS Nano, Zero S, Luxe X, Luxe QS, Osmall 2, and Gen PT 60.
The first batch of products that have been certified by MoIAT has arrived in the United Arab Emirates and has undergone tax inspection. This enables distributors, retailers, and consumers to legally sell, stock, and purchase VAPORESSO products. Additionally, all future VAPORESSO products will be registered with MoIAT.
The United Arab Emirates government has implemented strict regulations to regulate the sale of e-cigarettes, electronic accessories, e-liquids, and tobacco products in the country. These regulations require e-cigarette manufacturers and companies to comply with the standards set by the Emirates Authority for Standardization and Metrology (ESMA). The e-cigarettes and related products must meet rigorous quality and safety requirements.
Disclaimer
This article is provided solely for professional research, industry discussion, and informational purposes. Any references to brands, companies, products, technologies, or policies are made for factual reporting and analytical purposes only, and do not constitute endorsement, recommendation, promotion, or advertising by 2Firsts.
Nicotine-containing products, including but not limited to cigarettes, e-cigarettes, heated tobacco products, and nicotine pouches, carry significant health risks. Readers are responsible for complying with all applicable laws and regulations in their respective jurisdictions, including age restrictions and access limitations.
The information contained in this article should not be regarded as investment, legal, medical, regulatory, or commercial advice. While 2Firsts strives to ensure the accuracy and reliability of its content, it does not assume liability for any direct or indirect loss arising from errors, omissions, inaccuracies, or reliance on the information contained herein.
This article is not intended for individuals below the legal age for accessing tobacco or nicotine-related information in their jurisdiction.
Copyright Notice
This article is either original content produced by 2Firsts or content reproduced, translated, summarized, or adapted from third-party sources with attribution where applicable. The intellectual property rights of the original content remain with 2Firsts or the respective original rights holders.
No individual or organization may copy, reproduce, distribute, republish, modify, translate, or otherwise use this content without prior authorization. Any unauthorized use may result in legal action.
For copyright-related inquiries, corrections, or removal requests, please contact: info@2firsts.com.
AI-Assisted Translation and Editing Notice
Portions of this article may have been translated, edited, or reviewed with the assistance of artificial intelligence tools to improve efficiency and readability. Due to the limitations of AI-assisted translation and editing, discrepancies, omissions, or inaccuracies may exist when compared with the original source.
Where applicable, readers are advised to refer to the original source for the most complete and accurate information. If you identify any errors or believe that any content infringes upon your rights, please contact us at info@2firsts.com, and we will review and address the matter promptly.
